Differences between agalsidase α and agalsidase β in the treatment of Fabry disease
- PMID: 28602212
- DOI: 10.1016/j.medcli.2017.03.054
Differences between agalsidase α and agalsidase β in the treatment of Fabry disease
Comment in
-
Reply.Med Clin (Barc). 2017 Sep 20;149(6):271-272. doi: 10.1016/j.medcli.2017.05.016. Epub 2017 Jun 23. Med Clin (Barc). 2017. PMID: 28651882 English, Spanish. No abstract available.
Comment on
-
Diagnosis and treatment of Fabry disease.Med Clin (Barc). 2017 Feb 9;148(3):132-138. doi: 10.1016/j.medcli.2016.09.047. Epub 2016 Nov 29. Med Clin (Barc). 2017. PMID: 27912900 Review. English, Spanish. No abstract available.
Similar articles
-
Spotlight on agalsidase beta in Fabry disease.BioDrugs. 2007;21(4):269-71. doi: 10.2165/00063030-200721040-00007. BioDrugs. 2007. PMID: 17628124 Review.
-
Treatment with agalsidase beta during pregnancy in Fabry disease.J Obstet Gynaecol Res. 2010 Apr;36(2):428-9. doi: 10.1111/j.1447-0756.2009.01164.x. J Obstet Gynaecol Res. 2010. PMID: 20492401
-
Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy.PLoS One. 2015 Jun 17;10(6):e0128351. doi: 10.1371/journal.pone.0128351. eCollection 2015. PLoS One. 2015. PMID: 26083343 Free PMC article.
-
Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5. doi: 10.1016/j.ymgme.2008.07.002. Epub 2008 Aug 12. Mol Genet Metab. 2008. PMID: 18701330 No abstract available.
-
Agalsidase alfa: a review of its use in the management of Fabry disease.BioDrugs. 2012 Oct 1;26(5):335-54. doi: 10.2165/11209690-000000000-00000. BioDrugs. 2012. PMID: 22946754 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical